Based on its recent analysis of the medication management systems market, Frost & Sullivan recognizes HealthOneMed with the 2012 North American Frost & Sullivan Award for New Product Innovation. There is a huge need to address elderly patients' need for medication management. This will not only improve adherence and response to treatment, but also enhance their quality of life. Currently, HealthOneMed's Dispense-A-Pill (DAP) Personal Medication Manager is most suited to address this need.
DAP is a tool for patients prescribed high levels of polypharmacy, who may have trouble in managing daily regimens and maintaining an independent lifestyle. DAP's combination of safety, personalization and capacity has made it a leader in the market.
"While other products can require a tedious, and potentially unsafe, loading process involving specific chambers in a tray, or manually separating pills into a table full of plastic cups, DAP has individual chambers within the device itself to hold the medications," said Frost & Sullivan Research Director Daniel Ruppar. "In addition, with a high load capacity of up to three months, DAP eliminates the need for frequent loading, which is necessary in competing products with load capacities of only 10 days."
DAP also controls the dosage levels and frequency for drugs that may require stricter controls, such as those for pain management. DAP's management capabilities also extend to non-pill medications, which is a huge help to patients since they may also need other delivery types such as liquids, injections and inhalers, in a multitude of daily-use drugs. DAP's ability to define personalized reminder messages, not only for medications but also for any health-related action (e.g. blood pressure monitoring), is another value-added capability that can make this solution the focal point of a patient's home care management. Further, if the patient does not acknowledge the reminders, the system notifies the patient's family or caregivers.
DAP targets areas of need and customer growth through its ability to be packaged as a medication management service by various healthcare providers, such as Personal Emergency Response Service (PERS) providers, home care agencies, smaller pharmacies, senior and assisted living centers, and other providers centered on a patient's living environment.
"Any product that seeks to assist with medication adherence should empower the patient to comply with the physician's recommended therapy regimen," said Ruppar. "HealthOneMed has recognized these needs in healthcare and has developed the DAP system to deliver on these points."
Each year, Frost & Sullivan presents this Award to the company that demonstrates innovation in developing a product. The recipient leverages leading edge technologies to offer value-added features while increasing the ROI for customers. In turn, the innovation enables the company to acquire new customers and increase their market penetration.
Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.
HealthOneMed's mission (healthonemed.com) is to "maximize the effective delivery of healthcare to people." Telehealth, the integration of telecommunications and healthcare, is central to HealthOneMed's vision of enabling individuals, regardless of location, to monitor and manage their health. The company's goal is to improve medical outcomes and an individual's quality of life, while also improving the management of healthcare resources and costs. HealthOneMed addresses medication non-adherence with its Dispense-a-Pill (DAP) Personal Medication Manager, a patented home-based device that integrates the disparate approaches of pill boxes, reminders, pill dispensers and medication alert products into a compact, easy-to-use device enabled by new technology developed and patented by HealthOneMed.
About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.